EP4257614C0
Pharmaceutical combinations comprising an anti-ly75 antibody
Abstract
This record has no abstract on file.
Term
11.5 yearsto projected expiry
Projected expiry 9 March 2038, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
52 members in 25 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 201703876 | United Kingdom | A | |
| 18710841 | European Patent Office (EPO) | A | |
| 2018055939 | European Patent Office (EPO) | W |
Members52
| Document | Office | Kind | |
|---|---|---|---|
| GB201703876D0 | United Kingdom | D0 | |
| ZA201905021A0 | South Africa | A0 | |
| CA3054904A1 | Canada | A1 | |
| WO2018162727A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201836638A | Taiwan Province of China | A | |
| UY37630A | Uruguay | A | |
| AR111265A1 | Argentina | A1 | |
| SG11201907207UA | Singapore | A | |
| AU2018232886A1 | Australia | A1 | |
| KR20190129056A | Republic of Korea | A | |
| CN110494448A | China | A | |
| IL269140A | Israel | A | |
| MX2019010673A | Mexico | A | |
| EA201991845A1 | Eurasian Patent Organization (EAPO) | A1 | |
| EP3592774A1 | European Patent Office (EPO) | A1 | |
| MA49977A | Morocco | A | |
| CR20190422A | Costa Rica | A | |
| US2020040086A1 | United States of America | A1 | |
| CO2019009815A2 | Colombia | A2 | |
| JP2020510039A | Japan | A | |
| PH12019502000A1 | Philippines | A1 | |
| ZA201905021B | South Africa | B | |
| ZA202004675B | South Africa | B | |
| US11365258B2 | United States of America | B2 | |
| US2022289851A1 | United States of America | A1 | |
| TWI789379B | Taiwan Province of China | B | |
| JP7220153B2 | Japan | B2 | |
| TW202317194A | Taiwan Province of China | A | |
| KR102538294B1 | Republic of Korea | B1 | |
| MY197735A | Malaysia | A | |
| CN110494448B | China | B | |
| MX2023008887A | Mexico | A | |
| CN116808198A | China | A | |
| EP4257614A2 | European Patent Office (EPO) | A2 | |
| EP4257614A3 | European Patent Office (EPO) | A3 | |
| UA128081C2 | Ukraine | C2 | |
| TWI844215B | Taiwan Province of China | B | |
| AU2024204404A1 | Australia | A1 | |
| AU2018232886B2 | Australia | B2 | |
| IL269140B1 | Israel | B1 | |
| IL269140B1 | Israel | B1 | |
| NZ757191A | New Zealand | A | |
| IL269140B2 | Israel | B2 | |
| EP3592774B1 | European Patent Office (EPO) | B1 | |
| EP3592774C0 | European Patent Office (EPO) | C0 | |
| EP4257614B1 | European Patent Office (EPO) | B1 | |
| EP4257614C0This record | European Patent Office (EPO) | C0 | |
| ES3026749T3 | Spain | T3 | |
| ES3027007T3 | Spain | T3 | |
| US12351635B2 | United States of America | B2 | |
| US2025297014A1 | United States of America | A1 | |
| UA130475C2 | Ukraine | C2 |
63 legal events, as 7 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Renewal fee for the european patent with unitary effect paidU20 | U20 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed in a validation state [announced via postgrant information from nat. office to epo]LapsedVS25 | VS25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Ip right review requestedST27 STATUS EVENT CODE: U-0-0-L10-L00 (AS PROVIDED BY THE NATIONAL OFFICE)L10 | L10 | CH | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a validation state [announced via postgrant information from nat. office to epo]LapsedVS25 | VS25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Request for unitary effect filedU01 | U01 | EP | |
| Unitary effect registeredU07 | U07 | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE PATENT HAS BEEN GRANTEDSTAA | STAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: GRANT OF PATENT IS INTENDEDSTAA | STAA | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Requests to designate patent in hong kongDE | DE | HK | |
| Designated contracting statesAK | AK | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Amendment of ipc main classPREVIOUS MAIN CLASS: C07K0016460000R079 | R079 | DE | |
| Amendment of ipc main classPREVIOUS MAIN CLASS: C07K0016460000R079 | R079 | DE | |
| Request for examination filed17P | 17P | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: REQUEST FOR EXAMINATION WAS MADESTAA | STAA | EP |
Numbers
- Publication
- 4257614
- Application
- 23175804
Titles3
- German
- PHARMAZEUTISCHE KOMBINATIONEN MIT EINEM ANTI-LY75-ANTIKÖRPER
- English
- PHARMACEUTICAL COMBINATIONS COMPRISING AN ANTI-LY75 ANTIBODY
- French
- COMBINAISONS PHARMACEUTIQUES COMPRENANT UN ANTICORPS ANTI-LY75
Classification
- CPC, 18
- A61K39/39558
- C07K16/2851
- A61K31/5365
- A61K31/519
- A61K47/6831
- A61K47/6849
- C07K16/2887
- A61P35/00
- A61P35/02
- C07K2317/21
- A61K2039/505
- C07K2317/73
- C07K2317/90
- C07K2317/34
- C07K2317/24
- A61K47/68033
- A61K2039/507
- A61K2300/00
- IPC, 7
- C07K16 28
- A61K31 505
- A61K39 395
- A61K47 68
- A61P35 00
- A61P35 02
- C07K16 46
Designated states4
- Contracting states, 1
- Türkiye
- Extension states, 1
- Montenegro
- Up participating states, 1
- Slovenia
- Validation states, 1
- Tunisia